Back to search

Article

Pentoxifylline Ameliorates Subclinical Atherosclerosis Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomized Pilot Trial

2024-07-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Diabetic kidney disease (DKD) is associated with a higher risk of cardiovascular disease (CVD). Pentoxifylline (PTF), a nonselective phosphodiesterase inhibitor with anti-inflammatory, antiproliferative, and antifibrotic actions, has demonstrated renal benefits in both clinical trials and meta-analyses. The present work aimed to study the effects of PTF on the p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2b959aa7-e99c-53e5-b04f-d70603048ff3
DOI
10.21203/rs.3.rs-4599387/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pentoxifylline Ameliorates Subclinical Atherosclerosis Progression in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Randomized Pilot TrialDOI 10.21203/rs.3.rs-4599387/v1
Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results.Semantic proximity
Serum Pentosidine Levels Are Associated with Early Declines in Estimated Glomerular Filtration Rate, Independent of Glycemic Status: A Cross-Sectional Analysis from the Fukuoka Epidemiological Study of AtherosclerosisSemantic proximity
Ticagrelor Monotherapy in Patients with Concomitant Diabetes Mellitus and Chronic Kidney Disease: A post hoc analysis of the GLOBAL LEADERS TrialSemantic proximity
A Mathematical Model of Glomerular Fibrosis in Diabetic Kidney Disease to Predict Therapeutic EfficacySemantic proximity
Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study).Semantic proximity
Association of genetic variants of pentraxin 3 rs3816527 with hypertension in Chronic kidney disease patients.Semantic proximity
A Preclinical Model of Obesity-Independent Metabolic Syndrome for Studying the Effects of Novel Antidiabetic Therapy Beyond Glycemic ControlSemantic proximity
Linagliptin, when compared to placebo, improves CD34+ve Endothelial Progenitor Cells in Type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin, a randomized controlled trial.Semantic proximity
[Roles of vascular smooth muscle cells phenotype transformation in mediating progression of diabetic macroangiopathy and current status of traditional Chinese medicine treatment].Semantic proximity
The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: Protocol for a Systematic Review.Semantic proximity
Efficacy and mechanism of Shenqi Compound in Inhibiting Diabetic Vascular CalcificationSemantic proximity
Effect of ACE and AT-2 inhibitors on mortality and progression to microalbuminuria in a nested case-control study of diabetic nephropathy in diabetes mellitus type 2: results from the GENDIAN study.Semantic proximity
Select a neighboring publication to make it the new centre.